All content for PodMed – Johns Hopkins Medicine Podcasts is the property of Johns Hopkins Medicine and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This week’s topics include hospital factors relative to readmission, hormone therapy, lymph node dissection in breast cancer, and the cost of bringing a new drug to market.
Program notes:
0:32 Cost of R and D versus profit in new drugs
1:32 Took 7.3 years
2:35 Reaping in sales far outstrips R and D
3:32 R and D with federal dollars
4:00 What is the long term impact of HRT
5:00 Should be reassuring for women
5:36 Lymph node dissection in breast cancer
6:36 Increases risk of complications
7:32 Least amount of therapy to be effective
7:48 Hospital factors in readmission
8:45 Patients readmitted to different hospitals
9:45 Need to correct poorly performing hospitals
10:31 End
Related blog: https://podblog.blogs.hopkinsmedicine.org/2017/09/18/drug-costs/
